27 related articles for article (PubMed ID: 3892075)
1. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
[TBL] [Abstract][Full Text] [Related]
2. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Haruta T; Kuroki S; Okura K; Kobayashi Y
Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
[TBL] [Abstract][Full Text] [Related]
3. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
[TBL] [Abstract][Full Text] [Related]
4. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
[TBL] [Abstract][Full Text] [Related]
5. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
[TBL] [Abstract][Full Text] [Related]
6. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Sunakawa K; Ishizuka Y
Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
[TBL] [Abstract][Full Text] [Related]
7. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
Mashimo K
Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
[No Abstract] [Full Text] [Related]
8. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
Stein GE; Gurwith MJ
Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
[TBL] [Abstract][Full Text] [Related]
9. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
Smith BR; LeFrock JL
Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
[TBL] [Abstract][Full Text] [Related]
10. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Todd PA; Benfield P
Drugs; 1990 Feb; 39(2):264-307. PubMed ID: 2184003
[TBL] [Abstract][Full Text] [Related]
11. Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Edelstein DR; Avner SE; Chow JM; Duerksen RL; Johnson J; Ronis M; Rybak LP; Bierman WC; Matthews BL; Kohlbrenner VM
Laryngoscope; 1993 Jan; 103(1 Pt 1):33-41. PubMed ID: 8421417
[TBL] [Abstract][Full Text] [Related]
12. [Augmentin].
Foster M
Antibiot Khimioter; 1992 Sep; 37(9):3-9. PubMed ID: 1444667
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
